Cover Image
市場調查報告書

體外診斷 (IVD) 的中國市場:2015∼2019年

IVD Market in China 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 331969
出版日期 內容資訊 英文 88 Pages
訂單完成後即時交付
價格
Back to Top
體外診斷 (IVD) 的中國市場:2015∼2019年 IVD Market in China 2015-2019
出版日期: 2015年06月03日 內容資訊: 英文 88 Pages
簡介

體外診斷(IVD)檢查是有助於人類或動物的診斷、篩檢、疾病管理,並在已控管的環境下施行。由於IVD檢查對患者及醫療從業員而言都相當便利,也漸漸普及到照護現場和自我檢驗中。預測中國的IVD市場在2014年到2019年間將以年複合成長率(CAGR)13.47%的速度擴大。

本報告提供中國的IVD市場相關調查,提供您市場趨勢,2015∼2019年的成長預測,各市場區隔趨勢,及加入此市場的主要企業簡介等資訊。

第1章 摘要整理

第2章 簡稱清單

第3章 本報告的範圍

  • 市場概要
  • 產品概要

第4章 市場調查方法

第5章 簡介

第6章 市場環境

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 中國的醫療結構

  • 民營化的高漲
  • 由於全球的製造商的醫療設備登記流程

第8章 全球的供應商及國內供應商的機會

  • 國內供應商
  • 全球的供應商

第9章 各用途市場市場區隔

  • 專門診斷
  • 糖尿病治療
  • 分子診斷
  • 組織診斷

第10章 各零件市場區隔

  • 試劑
  • 設備
  • 服務
  • 中國的IVD試劑市場
  • 中國的IVD設備市場
  • 中國的IVD服務市場

第11章 各技術市場區隔

  • POC檢驗
  • 免疫檢測
  • 臨床化學
  • 微生物學
  • 血液學
  • 其他

第12章 各終端用戶市場區隔

  • 醫院及診斷測試所
  • 居家照護
  • 學術機構,研究機關

第13章 購買標準

第14章 市場成長的促進要素

第15章 促進要素與其影響

第16章 市場課題

第17章 促進要素的影響與課題

第18章 市場趨勢

第19章 趨勢及其影響

第20章 供應商環境

  • 競爭模式
  • 市場佔有率分析:2014年
  • 其他的潛力供應商

第21章 主要供應商分析

  • Abbott Diagnostics
  • BioMeriux
  • Danaher
  • Roche Diagnostics

第22章 本系列的其他報告

圖表

目錄
Product Code: IRTNTR5997

About IVD

IVD tests are helpful in diagnosis, screening, and disease management in humans and animals. These tests are usually performed in controlled environment, and they include blood analysis for the sign of infection and urine for the presence of glucose. The purpose of IVD test is not only to direct therapeutic effect but also to provide the health status of a patient. IVD plays an important role in supporting the decision making for clinical conditions. These advances have led to the development of point of care and self-test, which are easy and convenient for patients and medical professionals to use. The self-test include pregnancy test, blood glucose monitoring, cholesterol testing, infectious disease testing, and cardiac biomarker tests. IVD test can be performed in various settings, including clinical laboratory, a physician's office, or at home.

Technavio's analysts forecast the IVD market in China to grow at a CAGR of 13.47% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the IVD market in China for the period 2015-2019. The market can be divided into three segments: consumables, instruments, and services. To calculate the market size, the report considers the revenue generated from the three segments.

Technavio's report, IVD Market in China 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Vendors

  • Abbott Laboratories
  • bioMerieux
  • Danaher
  • F. Hoffmann-La Roche

Other Prominent Vendors

  • Alere
  • Atlas Link Biotech
  • Autobio Diagnostics
  • Bioneovan
  • Bio-Rad Laboratories
  • Bioptik Technology
  • Boson Biotech
  • C&G Biotech
  • Changchun Wancheng Bio-elect
  • Changsha City Epower Electronics & Science
  • Cepheid
  • Chongqing Haray International Business
  • Cusabio Biotech
  • Dako
  • Fudakang Ind'l
  • GE Healthcare
  • Grifols
  • Guangzhou Maya Medical Equipment
  • Hologic
  • Illumina
  • Innovation Biotech
  • Intec Products
  • Jiaxing Smir Medical Devices
  • Jiangxi Zhongchenda Industrial Investment
  • Johnson & Johnson
  • Luminex
  • Nantong Egens Biotechnology Company
  • Nantong Voyage International Trade
  • PerkinElmer
  • Qiagen
  • Quicking Biotech
  • Quest Diagnostics
  • Secure Detect
  • Shanghai Jiuyi International Trade
  • Shanghai Outdo Biotech
  • Shenzhen Fitconn Technology
  • Siemens Healthcare
  • Shiny Health Import & Export
  • Snibe
  • Sunrising Enterprise
  • Wuhan HNC Technology
  • Yilongyatu
  • Yuan Yu Bio-Tech
  • Zhejiang Orient Gene Biotech

Market Driver

  • Rise in Geriatric Population
  • For a full, detailed list, view our report

Market Challenge

  • Challenges for International Vendors
  • For a full, detailed list, view our report

Market Trend

  • Change in Healthcare System
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Healthcare Structure in China

  • 07.1. Rise in Privatization
  • 07.2. Registration Process of Medical Devices for Global Manufacturers

08. Opportunities for Global and Local Vendors

  • 08.1. Local Vendors
    • 08.1.1. Challenges for Local Vendors
  • 08.2. Global Vendors
    • 08.2.1. Challenges for Global Vendors

09. Market Segmentation by Application

  • 09.1. Professional Diagnostics
  • 09.2. Diabetic Care
  • 09.3. Molecular Diagnostics
  • 09.4. Tissue Diagnostics

10. Market Segmentation by Component

  • 10.1. Reagents
  • 10.2. Instruments
  • 10.3. Services
  • 10.4. IVD Reagents Market in China
    • 10.4.1. Market Size and Forecast
  • 10.5. IVD Instruments Market in China
    • 10.5.1. Market Size and Forecast
  • 10.6. IVD Services Market in China
    • 10.6.1. Market Size and Forecast

11. Market Segmentation by Technique

  • 11.1. POC Testing
  • 11.2. Immunoassays
  • 11.3. Clinical Chemistry
  • 11.4. Microbiology
  • 11.5. Hematology
  • 11.6. Others

12. Market Segmentation by End-user

  • 12.1. Hospitals and Diagnostic Laboratories
  • 12.2. Home Care
  • 12.3. Academic and Research Institutes

13. Buying Criteria

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape

  • 20.1. Competitive Scenario
    • 20.1.1. Key News
    • 20.1.2. Mergers and Acquisitions
  • 20.2. Market Share Analysis 2014
    • 20.2.1. Multinational Companies
    • 20.2.2. Domestic Enterprises
  • 20.3. Other Prominent Vendors

21. Key Vendor Analysis

  • 21.1. Abbott Diagnostics
    • 21.1.1. Key Facts
    • 21.1.2. Business Overview
    • 21.1.3. Geographical Presence
    • 21.1.4. SWOT Analysis
  • 21.2. bioMeriux
    • 21.2.1. Key Facts
    • 21.2.2. Business Overview
    • 21.2.3. Business Segmentation by Revenue 2013
    • 21.2.4. Geographical Segmentation by Revenue 2013
    • 21.2.5. Business Strategy
    • 21.2.6. Recent Developments
    • 21.2.7. SWOT Analysis
  • 21.3. Danaher
    • 21.3.1. Key Facts
    • 21.3.2. Business Overview
    • 21.3.3. Business Segmentation
    • 21.3.4. Revenue by Business Segmentation
    • 21.3.5. Revenue Comparison 2012 and 2013
    • 21.3.6. Segmentation by Geography
    • 21.3.7. Business Strategy
    • 21.3.8. Key Information
    • 21.3.9. SWOT Analysis
  • 21.4. Roche Diagnostics
    • 21.4.1. Key Facts
    • 21.4.2. Business Overview
    • 21.4.3. Business Segmentation by Revenue 2014
    • 21.4.4. Business Segmentation by Revenue 2013 and 2014
    • 21.4.5. Geographical Segmentation by Revenue 2014
    • 21.4.6. Business Strategy
    • 21.4.7. Recent Developments
    • 21.4.8. SWOT Analysis

22. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: IVD Market in China 2014-2019 ($ millions)
  • Exhibit 3: Healthcare Reforms in China
  • Exhibit 4: Timeline of Privatization of China's Healthcare System
  • Exhibit 5: Segmentation of IVD Market in China by Application
  • Exhibit 6: Segmentation of IVD Market in China by Application 2014
  • Exhibit 7: Segmentation of IVD Market in China by Component
  • Exhibit 8: Segmentation of IVD Market in China by Component in 2014
  • Exhibit 9: IVD Reagents Market in China 2014-2019 ($ millions)
  • Exhibit 10: IVD Instruments Market in China 2014-2019 ($ millions)
  • Exhibit 11: IVD Services Market in China 2014-2019 ($ millions)
  • Exhibit 12: Segmentation of IVD Market in China by Component in 2014-2019
  • Exhibit 13: Segmentation of IVD Market in China by Component in 2014-2019 ($ millions)
  • Exhibit 14: Segmentation of IVD Market in China by Technique
  • Exhibit 15: Segmentation of IVD Market in China by Technique 2014
  • Exhibit 16: Segmentation of IVD Market in China by End-user
  • Exhibit 17: Segmentation of IVD Market in China by End-user 2014
  • Exhibit 18: Healthcare Expenditure in China 2006 and 2011
  • Exhibit 19: Healthcare Expenditure in China 2005-2014
  • Exhibit 20: Number of Medical Institutes in China until 2012
  • Exhibit 21: Types of IVD Manufacturer in China
  • Exhibit 22: Key Takeaways: Abbott Diagnostics
  • Exhibit 23: Key Takeaways: bioMerieux
  • Exhibit 24: Key Takeaways: Danaher
  • Exhibit 25: Initiatives by Roche Diagnostics in 2014 to Improve Access to Healthcare
  • Exhibit 26: Key Takeaways: Roche Diagnostics
  • Exhibit 27: Abbott Diagnostics: Geographical Presence
  • Exhibit 28: bioMeriux: Business Segmentation by Revenue 2013
  • Exhibit 29: bioMeriux: Geographical Segmentation by Revenue 2013
  • Exhibit 30: Danaher: Business Segmentation
  • Exhibit 31: Danaher: Business Segmentation 2013
  • Exhibit 32: Danaher: Revenue by Business Segmentation 2012 and 2013 ($ million)
  • Exhibit 33: Danaher: Revenue by Geographical Segmentation 2013
  • Exhibit 34: Roche Diagnostics: Business Segmentation by Revenue 2014
  • Exhibit 35: Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billion)
  • Exhibit 36: Roche Diagnostics: Geographical Segmentation by Revenue 2014
Back to Top